Business Description

RetinalGenix Technologies Inc
NAICS : 423450 SIC : 5047
ISIN : US76133Y1055
Description
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.
Name Current Vs Industry Vs History
Debt-to-Equity -0.04
Debt-to-EBITDA -0.02
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 100
9-Day RSI 99.92
14-Day RSI 97.87
6-1 Month Momentum % -22.05
12-1 Month Momentum % -61.11

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.3
Shareholder Yield % 0.02
Name Current Vs Industry Vs History
ROA % -44807.14
ROIC % -4243.9

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -29.84
EV-to-EBITDA -29.85
EV-to-FCF -178.5
Earnings Yield (Greenblatt) % -3.35
FCF Yield % -0.56

Financials (Next Earnings Date:2024-05-17 Est.)

RTGN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:RTGN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

RetinalGenix Technologies Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.12
Beta 0
Volatility % 59.67
14-Day RSI 97.87
14-Day ATR ($) 0.001127
20-Day SMA ($) 3.5
12-1 Month Momentum % -61.11
52-Week Range ($) 3 - 9
Shares Outstanding (Mil) 17.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

RetinalGenix Technologies Inc Filings

Filing Date Document Date Form
No Filing Data

RetinalGenix Technologies Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

RetinalGenix Technologies Inc Frequently Asked Questions

What is RetinalGenix Technologies Inc(RTGN)'s stock price today?
The current price of RTGN is $3.50. The 52 week high of RTGN is $9.00 and 52 week low is $3.00.
When is next earnings date of RetinalGenix Technologies Inc(RTGN)?
The next earnings date of RetinalGenix Technologies Inc(RTGN) is 2024-05-17 Est..
Does RetinalGenix Technologies Inc(RTGN) pay dividends? If so, how much?
RetinalGenix Technologies Inc(RTGN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1